Abstract
“This is just the beginning, as the conversation between regulatory agencies and different pharmaceutical stakeholders is taking place to address challenges and concerns relating to innovative pharmaceutical approaches. Accordingly, it is likely that more 3D-printed medical device products will be released to the market in the next few years.”
| Original language | English |
|---|---|
| Pages (from-to) | 359-362 |
| Number of pages | 4 |
| Journal | Therapeutic Delivery |
| Volume | 13 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - Jul 2022 |
Access to Document
- 3D printing for the development of implantable devices for cardiovascular disease treatment
Copyright 2023 the authors. This is an open access article published under a Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.